Baroni A, De Luca A, De Filippis A, Petrazzuolo M, Manente L, Nicoletti R, Tufano M A, Buommino E
Department of Dermatology, Second University of Naples, Naples, Italy.
Cell Prolif. 2009 Aug;42(4):541-53. doi: 10.1111/j.1365-2184.2009.00609.x. Epub 2009 May 22.
Melanoma cells take advantage of impaired ability to undergo programmed cell death in response to different external stimuli and chemotherapeutic drugs; this makes prevention of tumour progression very difficult. The aim of this study was to demonstrate whether 3-O-methylfunicone (OMF), a metabolite of Penicillium pinophilum, has the ability to arrest cell population growth and to induce apoptosis in A375P (parental) and A375M (metastasis derivatived) melanoma cell lines.
Cell proliferation and apoptosis were analysed by flow cytometry, DNA fragmentation, caspase-3 and caspase-9 activation, and PARP-1 cleavage.
We demonstrated that OMF affected cell proliferation in a time- and dose-dependent manner, reaching the best effect at concentration of 80 microg/ml for 24 h. Flow cytometry revealed that OMF caused significant G(2) phase arrest, which was associated with marked decrease in cyclin B1/p34(cdc2) complex and p21 induction. OMF also induced marked decrease of survivin expression. Reduced levels of apoptosis were evident after silencing p21 expression in both cell lines. Finally, the effect exercised by OMF on hTERT and TEP-1 gene expression confirmed the ability of this molecule to interfere with replicative ability of cells.
The results reported here seem to suggest that OMF as a promising molecule to include in strategies for treatment of melanoma.
黑色素瘤细胞利用其在应对不同外部刺激和化疗药物时程序性细胞死亡能力受损的特点;这使得预防肿瘤进展非常困难。本研究的目的是证明嗜松青霉的一种代谢产物3 - O - 甲基富尼酮(OMF)是否具有阻止细胞群体生长并诱导A375P(亲本)和A375M(转移衍生)黑色素瘤细胞系凋亡的能力。
通过流式细胞术、DNA片段化、半胱天冬酶 - 3和半胱天冬酶 - 9激活以及聚(ADP - 核糖)聚合酶 - 1(PARP - 1)裂解分析细胞增殖和凋亡。
我们证明OMF以时间和剂量依赖性方式影响细胞增殖,在浓度为80μg/ml处理24小时时达到最佳效果。流式细胞术显示OMF导致显著的G₂期阻滞,这与细胞周期蛋白B1/p34(cdc2)复合物的显著减少和p21的诱导有关。OMF还诱导存活素表达显著降低。在两种细胞系中沉默p21表达后,凋亡水平降低明显。最后,OMF对hTERT和TEP - 1基因表达的影响证实了该分子干扰细胞复制能力的能力。
此处报道的结果似乎表明OMF是一种有前景的分子,可纳入黑色素瘤治疗策略中。